Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2003
10/16/2003WO2003011907A3 Receptor, the use thereof, and mouse antibodies
10/16/2003WO2003006055A9 Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit
10/16/2003WO2003005036A3 Epf receptor assays, compounds and therapeutic compositions
10/16/2003WO2003004520A3 Mycobacterial antigens expressed during latency
10/16/2003WO2002100896A3 Method for diagnosing cancer susceptibility
10/16/2003WO2002098899A3 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
10/16/2003WO2002097043A3 Wnv core protein/capsid interacting protein and uses of the same
10/16/2003WO2002088081A3 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
10/16/2003WO2002077211A3 A virus (cryptovirus) within the rubulavirus genus and uses therefor
10/16/2003WO2002070655A3 Mouse cytokine receptor
10/16/2003WO2002068677A8 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer
10/16/2003WO2002068675A3 Product, method and system for identifying collagenase-cleaved type ii collagen
10/16/2003WO2002060930A3 Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith
10/16/2003WO2002032954A3 Phosphorylation modifications of apoptin
10/16/2003WO2002008442A3 Means and methods for raising antibody concentration in compartments of the body of a non human animal
10/16/2003WO2001088148A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/16/2003US20030195349 H. pylori flbA polypeptides, immunogenic and vaccinating compositions comprising H. pylori flbA polypeptides, and compositions for detection of an infection comprising H. pylori flbA polypeptides
10/16/2003US20030195347 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195346 An isolated amino acid sequences are expressed by a cell; for use as human secreted proteins such as human insulin, interferon, Factor VIII, human growth hormones
10/16/2003US20030195345 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195344 A DNA libraries having the vector sequences for coding the membrane receptor proteins, or fusion proteins, for binding the membrane-bound proteins; drug delivery target to specific cell site
10/16/2003US20030195338 Concatameric immunoadhesion
10/16/2003US20030195337 UL16 binding protein 4
10/16/2003US20030195336 Nucleic acid and polypeptide compositions encoding lepidopteran-toxic polypeptides
10/16/2003US20030195334 Cell culturing and expressing the protein, chimeric polypeptides, fusion proteins; membrane protein receptor is used to bind the protein drugs thrombolytic agents, interferons, interleukins, erythropoietins
10/16/2003US20030195333 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195156 Tumor necrosis factors; cytokines; immunoglobulins; autoimmune diseases
10/16/2003US20030195153 Comprises metalloproteinase (stromelysin) inhibitors
10/16/2003US20030195148 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194794 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194793 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194792 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194791 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194790 DNA sequences coding for ester-group-cleaving enzymes
10/16/2003US20030194779 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194778 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194777 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194776 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194775 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194774 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194773 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194772 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194771 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194770 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194769 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194768 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194767 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194766 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194765 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194761 Novel nucleic acid sequences encoding human fibroblast growth factor-like polypeptides
10/16/2003US20030194760 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194746 For diagnosis, prognosis, prophylaxis
10/16/2003US20030194744 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194739 Using cancer specific genes
10/16/2003US20030194732 For treating neoplastic diseases by testing responsiveness to interferons
10/16/2003US20030194720 Human ion channels
10/16/2003US20030194414 Replikin peptides and antibodies therefore
10/16/2003US20030194411 Peptide compositions for the treatment and prevention of HIV infection
10/16/2003US20030194408 Antibody which specifically binds to at least two variants of an epitope of an HIV-1 Tat protein
10/16/2003US20030194407 103P2D6: tissue specific protein highly expressed in various cancers
10/16/2003US20030194406 P-cadherin as a target for anti-cancer therapy
10/16/2003US20030194405 Contain at least one CDR derived from a combinatorial antibody library.
10/16/2003US20030194404 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders
10/16/2003US20030194403 Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
10/16/2003US20030194402 Methods of sustained treatment of fistulas in crohn's disease with chimeric anti-TNF antibodies
10/16/2003US20030194401 Agent that interacts with MHC beta2-microglobulin HLA class 1 molecules located on the tumor cell surface
10/16/2003CA2779639A1 Multivalent constructs for therapeutic and diagnostic applications
10/16/2003CA2482138A1 La1 - the genome of a lactobacillus strain
10/16/2003CA2481925A1 Therapeutic agent for patients having human fc.gamma.riiia
10/16/2003CA2481920A1 Antibody composition-containing medicament
10/16/2003CA2481837A1 Production process for antibody composition
10/16/2003CA2481829A1 Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine
10/16/2003CA2481710A1 Method of judging leukemia, pre-leukemia or aleukemic malignant blood disease and diagnostic therefor
10/16/2003CA2481658A1 Method of enhancing of binding activity of antibody composition to fcy receptor iiia
10/16/2003CA2481657A1 Cells of which genome is modified
10/16/2003CA2481656A1 Cells in which activity of the protein involved in transportation of gdp-fucose is reduced or lost
10/16/2003CA2481437A1 Motif-grafted hybrid polypeptides and uses thereof
10/16/2003CA2481090A1 Novel pancortin-pablo protein interactions and methods of use thereof
10/16/2003CA2481039A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003CA2480450A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003CA2480052A1 Antibodies that specifically bind to gmad
10/16/2003CA2479927A1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
10/16/2003CA2479049A1 Nucleic acid and corresponding protein entitled 238p1b2 useful in treatment and detection of cancer
10/16/2003CA2477935A1 Multivalent constructs for therapeutic and diagnostic applications
10/16/2003CA2476551A1 Methods and compositions for in vivo clearance of pathogens
10/15/2003EP1353180A2 Labelling and selection of molecules
10/15/2003EP1352959A1 A method for in vitro molecular evolution of protein function
10/15/2003EP1352956A1 Inhibition of DNA methyltransferase
10/15/2003EP1352092A2 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
10/15/2003EP1352088A2 Genes comprising coding mononucleotide microsatellites or dinucleotide microsatellites that can be isolated from tumor cells
10/15/2003EP1352085A1 P2y purinergic receptor expression for identifying preneoplastic and neoplastic states
10/15/2003EP1352070A2 A fibrin/fibrinogen-binding conjugate
10/15/2003EP1352065A2 Polypetides and nucleic acids encoding same
10/15/2003EP1352063A2 Receptor nucleic acids and polypeptides
10/15/2003EP1352056A2 Polypeptides
10/15/2003EP1352054A2 Aspergillus ochraceus 11 alpha hydrolase and oxidoreductase
10/15/2003EP1351991A2 Ternary biomolecule/polymer/surface-based immobilization systems
10/15/2003EP1351989A2 Improved compositions and methods for producing antibodies to low molecular weight analytes
10/15/2003EP1351988A1 Group 2 allergen specific ige-fabs and igg molecules and use thereof
10/15/2003EP1351987A2 Hybrid antibodies
1 ... 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 ... 1494